Company intelligence / Profile preview

Watermill Group

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Watermill Group is a Boston-based private investment firm focused on acquiring, operating, and improving middle-market companies through strategic transformation. The firm is not a life sciences, biotech, pharma, or healthcare operating company; instead, it functions as a private equity investor across industrial, manufacturing, business services, distribution, and related sectors. Watermill emphasizes hands-on operational improvement rather than drug development or healthcare product commercialization. It has a multi-decade track record of buyouts, carve-outs, and strategic investments in North America and Europe.

Industry: Investors

Beyond the preview

Go deeper on Watermill Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Watermill Group.

Explore the full profile